Related references
Note: Only part of the references are listed.Patients with antiphosholipid syndrome and thrombotic recurrences: A real world observation (the Piedmont cohort study)
M. Bazzan et al.
LUPUS (2016)
Clinical significance and correlations between anti-β2 glycoprotein I IgA assays in antiphospholipid syndrome and/or systemic lupus erythematosus
Anne E. Tebo et al.
CLINICA CHIMICA ACTA (2016)
Recognition and management of antiphospholipid syndrome
Maria Gerosa et al.
CURRENT OPINION IN RHEUMATOLOGY (2016)
Evaluation of three fully automated immunoassay systems for detection of IgA anti-beta 2-glycoprotein I antibodies
D. Perez et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2016)
Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events
Jose A. Martinez-Flores et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)
Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
Charis Pericleous et al.
PLOS ONE (2016)
The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome
Anna Brusch
ANTIBODIES (2016)
Patient-level analysis of five international cohorts further confirms the efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies
Laurent Arnaud et al.
AUTOIMMUNITY REVIEWS (2015)
Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review
O. Amengual et al.
LUPUS (2015)
Examining the prevalence of non-criteria anti-phospholipid antibodies in patients with anti-phospholipid syndrome: a systematic review
Veronica Rodriguez-Garcia et al.
RHEUMATOLOGY (2015)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
Gary S. Collins et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
Gary S. Collins et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
R. Cervera et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Association of Early Kidney Allograft Failure with Preformed IgA Antibodies to β2-Glycoprotein I
Jose M. Morales et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Differential assay reactivity of immunglobulin A anti-β2 glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing
David B. Hood et al.
EUROPEAN JOURNAL OF RHEUMATOLOGY (2015)
14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends
Maria Laura Bertolaccini et al.
AUTOIMMUNITY REVIEWS (2014)
Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study
P. Mustonen et al.
LUPUS (2014)
Hughes syndrome/APS. 30 years on, what have we learnt? Opening talk at the 14th International Congress on antiphospholipid antibodies Rio de Janiero, October 2013
Graham R. V. Hughes
LUPUS (2014)
Contribution of anti-β2glycoprotein I IgA antibodies to the diagnosis of anti-phospholipid syndrome: potential interest of target domains to discriminate thrombotic and non-thrombotic patients
Laura Despierres et al.
RHEUMATOLOGY (2014)
Isolated IgA Anti-beta 2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
Raquel Ruiz-Garcia et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Heterogeneity between Diagnostic Tests for IgA anti-Beta2 Glycoprotein I: Explaining the Controversy in Studies of Association with Vascular Pathology
Jose A. Martinez-Flores et al.
ANALYTICAL CHEMISTRY (2013)
Value of Isolated IgA Anti-β2-Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome
Vijaya Murthy et al.
ARTHRITIS AND RHEUMATISM (2013)
Thrombotic recurrences and bleeding events in APS vascular patients: A review from the literature and a comparison with the APS Piedmont Cohort
M. Bazzan et al.
AUTOIMMUNITY REVIEWS (2013)
The clinical relevance of IgA anticardiolipin and IgA anti-β2 glycoprotein I antiphospholipid antibodies A systematic review
Hector Meijide et al.
AUTOIMMUNITY REVIEWS (2013)
Antiphospholipid antibodies and the risk of recurrence after a first episode of venous thromboembolism: a systematic review
David Garcia et al.
BLOOD (2013)
Clinical Significance of IgA Anti-Cardiolipin and IgA Anti-β2Glycoprotein I Antibodies
Laura Andreoli et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
International Consensus Guidelines on Anticardiolipin and Anti-beta 2-Glycoprotein I Testing: Report From the 13th International Congress on Antiphospholipid Antibodies
Gabriella Lakos et al.
ARTHRITIS AND RHEUMATISM (2012)
Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review
Andrej Artenjak et al.
AUTOIMMUNITY REVIEWS (2012)
Does seronegative antiphospholipid syndrome really exist?
Ricard Cervera et al.
AUTOIMMUNITY REVIEWS (2012)
IgA antibodies against β2 glycoprotein I in hemodialysis patients are an independent risk factor for mortality
Antonio Serrano et al.
KIDNEY INTERNATIONAL (2012)
Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study
Amelia Ruffatti et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study
Vittorio Pengo et al.
BLOOD (2011)
Association of IgA Anti-beta 2 Glycoprotein I with Clinical and Laboratory Manifestations of Systemic Lupus Erythematosus
Taraneh Mehrani et al.
JOURNAL OF RHEUMATOLOGY (2011)
Primary Thrombosis Prophylaxis in Antiphospholipid Antibody-Positive Patients: Where Do We Stand?
Medha Barbhaiya et al.
CURRENT RHEUMATOLOGY REPORTS (2011)
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of a series of 280 patients from the CAPS Registry
Ricard Cervera et al.
JOURNAL OF AUTOIMMUNITY (2009)
Relaxing the rule of ten events per variable in logistic and Cox regression
Eric Vittinghoff et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Clinical significance of IgA anticardiolipin and anti-β2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
M Samarkos et al.
CLINICAL RHEUMATOLOGY (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Clinical laboratory testing for the antiphospholipid syndrome
SS Pierangeli et al.
CLINICA CHIMICA ACTA (2005)
A prospective study of antibodies to β2-glycoprotein I and prothrombin, and risk of thrombosis
R Forastiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples
EF Schisterman et al.
EPIDEMIOLOGY (2005)
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome
D Erkan et al.
RHEUMATOLOGY (2002)
Antiphospholipid syndrome
SC Keswani et al.
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2002)
Value of autoantibodies to β2-glycoprotein 1 in the diagnosis of antiphospholipid syndrome
MAP Audrain et al.
RHEUMATOLOGY (2002)
Share Paper
